The purpose of this observational study is to describe the time to lipid-lowering drug implementation in the management of dyslipidemic patients, according to the cardiovascular risk level.

Inclusion Criteria:

• Diagnosis of dyslipemia made less than 2 years
• Treated by a lipid-lowering drug
• Agree to take part in the survey

Exclusion Criteria:

• Patient included in a clinical trial

First three consecutive dyslipidemic patients seen by GP